BioLineRx
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioLineRx and other ETFs, options, and stocks.About BLRX
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors.
CEOPhilip Adam Serlin
CEOPhilip Adam Serlin
Employees24
Employees24
HeadquartersModi'in, HaMerkaz
HeadquartersModi'in, HaMerkaz
Founded2003
Founded2003
Employees24
Employees24
BLRX Key Statistics
Market cap12.17M
Market cap12.17M
Price-Earnings ratio-1.38
Price-Earnings ratio-1.38
Dividend yield—
Dividend yield—
Average volume45.70K
Average volume45.70K
High today$2.62
High today$2.62
Low today$2.51
Low today$2.51
Open price$2.58
Open price$2.58
Volume9.45K
Volume9.45K
52 Week high$4.56
52 Week high$4.56
52 Week low$2.15
52 Week low$2.15
BLRX News
Investing.com 3d
BioLineRx, Hemispherian to present GLIX1 data at EANO meeting - Investing.com...
TipRanks 3d
BioLineRx and Hemispherian to Showcase GLIX1 Glioblastoma Data and Trial Design at EANO 2026Bioline RX Ltd Sponsored ADR ( (BLRX) ) has provided an update. On September 10, 2026, BioLineRx and Hemispherian announced that two abstracts on their lead as...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.